 |
| 08:30~09:20 |
Registration |
| 09:20~09:25 |
Welcome address |
Yonsei Univ., Korea |
| 09:25~09:30 |
Congratulatory remark |
MOST, Korea |
Session I : Regulation of Self Renewal
Chairs: Kye-Seong Kim and Hiromitsu Nakauchi |
| 09:30-09:55 |
MicroRNAs, as a factor regulating cellular function of stem cells |
Kye-Seong Kim
Hanyang Univ., Korea |
| 09:55-10:30 |
Epigenetic regulation of stem cell self-renewal by polycomb group protein, Bmi-1 |
Hiromitsu Nakauchi
Univ. of Tokyo, Japan |
| 10:30-10:55 |
Role of growth factors and neurotransmitters in regulation of embryonic stem cell proliferation |
Ho-Jae Han
Chonnam National Univ., Korea |
| 10:55-11:15 |
Coffee break |
Session ¥± : Prospect of Stem Cell Research
Chairs: Paul J Simmons and Ronald D McKay |
| 11:15-11:50 |
The Yin and Yang of MSC |
Paul J Simmons
President of ISSCR, USA |
| 11:50-12:25 |
The use of embryonic stem cells in science and medicine |
Ronald D McKay
National Institutes of Health, USA |
| 12:25-13:55 |
Lunch |
Session ¥² : Differentiation and Application of Stem Cells
Chairs: Il-Hoan Oh and Andrew G Elefanty |
| 13:55-14:20 |
Molecular and cellular targeting of spinal cord injury; From molecular signature to stem cell therapy |
Soo-Kyung Kang
Pusan National Univ., Korea |
| 14:20-14:55 |
In vitro differentiation of embryonic stem cells |
Andrew G Elefanty
Monash Univ., Australia |
| 14:55-15:20 |
Mesenchymal stem cells for bone marrow transplantation; Roles in hematopoietic regenerations and possible transformation |
Il-Hoan Oh
Catholic Univ. of Korea, Korea |
| 15:20-15:45 |
Efficient induction of dopamine neurons/oligodendrocytes from human ES cells |
Dong-Wook Kim
SCRC, Korea |
| 15:45-16:10 |
Coffee break |
Session ¥³ : Pre-Clinical and Clinical Applications
Chairs: Gilson Khang and Miles G Cunningham |
| 16:10-16:35 |
Umbilical cord blood-derived stem cells for future regenerative medicine |
Kyung-Sun Kang
Seoul National Univ., Korea |
| 16:35-17:10 |
Antidepressant and anxiolytic effects of stem cell-derived monoaminergic neuronal grafts: new horizons and innovative delivery methods |
Miles G Cunningham
Harvard Medical School, USA |
| 17:10-17:35 |
From endothelial progenitor cells to MAGIC-CELL clinical trial; an example of ¡®bench to bedside¡¯ |
Hyo-Soo Kim
Seoul National Univ., Korea |
| 17:35 |
Closing remark |
Dong-Wook Kim
Director, SCRC, Korea |
